TY - JOUR
T1 - 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease
T2 - A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
AU - Writing Committee Members
AU - Gornik, Heather L.
AU - Aronow, Herbert D.
AU - Goodney, Philip P.
AU - Arya, Shipra
AU - Brewster, Luke Packard
AU - Byrd, Lori
AU - Chandra, Venita
AU - Drachman, Douglas E.
AU - Eaves, Jennifer M.
AU - Ehrman, Jonathan K.
AU - Evans, John N.
AU - Getchius, Thomas S.D.
AU - Gutiérrez, J. Antonio
AU - Hawkins, Beau M.
AU - Hess, Connie N.
AU - Ho, Karen J.
AU - Jones, W. Schuyler
AU - Kim, Esther S.H.
AU - Kinlay, Scott
AU - Kirksey, Lee
AU - Kohlman-Trigoboff, Debra
AU - Long, Chandler A.
AU - Pollak, Amy West
AU - Sabri, Saher S.
AU - Sadwin, Lawrence B.
AU - Secemsky, Eric A.
AU - Serhal, Maya
AU - Shishehbor, Mehdi H.
AU - Treat-Jacobson, Diane
AU - Wilkins, Luke R.
N1 - Publisher Copyright:
© 2024 American College of Cardiology Foundation and the American Heart Association, Inc. Published by Elsevier.
PY - 2024/6/18
Y1 - 2024/6/18
N2 - Aim: The “2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease” provides recommendations to guide clinicians in the treatment of patients with lower extremity peripheral artery disease across its multiple clinical presentation subsets (ie, asymptomatic, chronic symptomatic, chronic limb-threatening ischemia, and acute limb ischemia). Methods: A comprehensive literature search was conducted from October 2020 to June 2022, encompassing studies, reviews, and other evidence conducted on human subjects that was published in English from PubMed, EMBASE, the Cochrane Library, CINHL Complete, and other selected databases relevant to this guideline. Additional relevant studies, published through May 2023 during the peer review process, were also considered by the writing committee and added to the evidence tables where appropriate. Structure: Recommendations from the “2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease” have been updated with new evidence to guide clinicians. In addition, new recommendations addressing comprehensive care for patients with peripheral artery disease have been developed.
AB - Aim: The “2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease” provides recommendations to guide clinicians in the treatment of patients with lower extremity peripheral artery disease across its multiple clinical presentation subsets (ie, asymptomatic, chronic symptomatic, chronic limb-threatening ischemia, and acute limb ischemia). Methods: A comprehensive literature search was conducted from October 2020 to June 2022, encompassing studies, reviews, and other evidence conducted on human subjects that was published in English from PubMed, EMBASE, the Cochrane Library, CINHL Complete, and other selected databases relevant to this guideline. Additional relevant studies, published through May 2023 during the peer review process, were also considered by the writing committee and added to the evidence tables where appropriate. Structure: Recommendations from the “2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease” have been updated with new evidence to guide clinicians. In addition, new recommendations addressing comprehensive care for patients with peripheral artery disease have been developed.
KW - ACC/AHA Clinical Practice Guidelines
KW - acute limb ischemia
KW - angioplasty
KW - ankle-brachial index
KW - anticoagulation therapy
KW - antiplatelet therapy
KW - antithrombotic therapy
KW - atherosclerosis
KW - atypical leg symptoms
KW - blood pressure lowering
KW - bypass graft/bypass grafting/surgical bypass
KW - cilostazol
KW - claudication/intermittent claudication
KW - critical limb ischemia/chronic limb-threatening ischemia
KW - diabetes
KW - diagnostic testing
KW - endovascular therapy
KW - exercise rehabilitation/exercise therapy/exercise training/supervised exercise
KW - foot care
KW - hybrid approach
KW - lipid lowering
KW - lower extremity/foot wound/ulcer
KW - medical management
KW - open revascularization
KW - percutaneous therapy
KW - peripheral artery disease/peripheral arterial disease/peripheral vascular disease/lower extremity arterial disease
KW - smoking/smoking cessation
KW - statin
KW - stenting
KW - thrombolysis
KW - vascular intervention
KW - vascular surgery
UR - http://www.scopus.com/inward/record.url?scp=85194579454&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85194579454&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2024.02.013
DO - 10.1016/j.jacc.2024.02.013
M3 - Article
C2 - 38743805
AN - SCOPUS:85194579454
SN - 0735-1097
VL - 83
SP - 2497
EP - 2604
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 24
ER -
